Benign Over Kisti Olan Asemptomatik Premenopozal Hastalarda Anksiyete Skorlaması

Aim: The aim of this study was to investigate the effect of oral contraceptive usage and follow-up management on the anxiety levels of asymptomatic premenopausal patients with benign ovarian cyst. Methods: Ninety asymptomatic premenopausal women were admitted to this prospective study. All of the women (21-39 years) underwent gynecological examination and transvaginal ultrasound examination. The patients with benign ovarian cyst were followed up in 3 months and divided into 2 groups. Although Group 1 was begun with oral contraceptive containing with ethinyl estradiol plus drospirenone, Group 2 was followed up without any medical treatment. Group 3 was the healthy control group without any ovarian cyst. Anxiety levels were measured by State Trait Inventory (STAI) when the patient firstly learned having cyst and after 3 months. Results: The demographic characteristics of the groups were similar. Cyst diameter and CA-125 levels were comparable between the group 1 and 2. Anxiety scores were statistically significant higher in follow-up group with ovarian cyst. Anxiety scores were lower in the oral contraceptive administered group than follow-up group. However, all of the groups that learned having benign ovarian cyst had increased anxiety scores comparing with healthy control. Conclusion: Having benign ovarian cyst without any malignancy suspicion was associated with increasing anxiety in women. Although oral contraceptive usage was not superior than following-up management for the benign ovarian cyst treatment, oral contraceptive administration might decrease patient s anxiety.